INMD
Closed
Inmode Ltd
14.83
+0.39 (+2.70%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 14.44
Day's Range: 14.3 - 15.155
Send
sign up or login to leave a comment!
When Written:
32.6
InMode Ltd is a medical technology company that specializes in developing and manufacturing innovative medical devices for the aesthetic and surgical markets. The company's products are based on its proprietary radiofrequency (RF) technology, which enables minimally invasive and non-invasive treatments for a wide range of aesthetic and surgical applications.
InMode's product portfolio includes devices for body contouring, facial rejuvenation, skin tightening, hair removal, and other cosmetic and surgical procedures. The company's flagship product, the BodyTite system, uses RF energy to liquefy fat and tighten skin, providing a minimally invasive alternative to traditional liposuction.
InMode was founded in 2008 and is headquartered in Yokneam, Israel. The company has a global presence, with operations in North America, Europe, Asia, and the Middle East. In 2019, InMode went public on the NASDAQ stock exchange under the ticker symbol "INMD."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
InMode's product portfolio includes devices for body contouring, facial rejuvenation, skin tightening, hair removal, and other cosmetic and surgical procedures. The company's flagship product, the BodyTite system, uses RF energy to liquefy fat and tighten skin, providing a minimally invasive alternative to traditional liposuction.
InMode was founded in 2008 and is headquartered in Yokneam, Israel. The company has a global presence, with operations in North America, Europe, Asia, and the Middle East. In 2019, InMode went public on the NASDAQ stock exchange under the ticker symbol "INMD."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








